Skip to main content

Table 4 Patients Using Lyophilized Preparations*

From: Subcutaneous Immunoglobulin-G Replacement Therapy with Preparations Currently Available in the United States for Intravenous or Intramuscular Use: Reasons and Regimens

     Monthly Dose No. of Infusions Details per Infusion
Patient Patient Age Weight    Per Per Dose Volume No. of Duration mL/kg/
No. Name (yr) (kg) (g) (mg/kg) Week Month (g) (cc) Sites (h) h/site
13 AT 15 40.0 30 750 1-2 5 6 40 2 8-9 0.059
14 CS 10 42.4 24 566 1 4 6 40 2 2-3 0.019
15 KA 14 65.8 24 365 1 4 6 40 2 2-3 0.121
16 LF 84 68.0 48 705 1 4 12 80 2 2-3 0.235
17 MC 22 70.9 60 845 1 4 12 80 4 2-3 0.112
18 WT 42 75.8 72 979 3 12 6 40 2 2 0.132
19 TSR 36 108.5 60 593 2-3 10 6 40 2 2 0.092
20 SR 49 124.0 54 433 1-2 5 12 80 2 3-4 0.092
  1. *Carimune NF or Panglobulin NF, unit dose of 6 g reconstituted with 40 cc of sterile water to give an immunoglobulin G concentration of 15%.
  2. One infusion per month is only 6 g.